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Radiation therapy is a cornerstone of modern management methods for malignancies
but is accompanied by diverse side effects. In the present study, we showed that food
additives such as polysorbate 80 (P80) exacerbate irradiation-induced gastrointestinal
(GI) tract toxicity. A 16S ribosomal RNA high-throughput sequencing analysis indicated
that P80 consumption altered the abundance and composition of the gut microbiota,
leading to severe radiation-induced GI tract injury. Mice harboring fecal microbes from
P80-treated mice were highly susceptible to irradiation, and antibiotics-challenged
mice also represented more sensitive to radiation following P80 treatment. Importantly,
butyrate, a major metabolite of enteric microbial fermentation of dietary fibers,
exhibited beneficial effects against P80 consumption-aggravated intestinal toxicity via
the activation of G-protein-coupled receptors (GPCRs) and maintenance of the intestinal
bacterial composition in irradiated animals. Moreover, butyrate had broad therapeutic
effects on common radiation-induced injury. Collectively, our findings demonstrate that
P80 are potential risk factors for cancer patients during radiotherapy and indicate that
butyrate might be employed as a therapeutic option to mitigate the complications
associated with radiotherapy.
Keywords: emulsifier, radiation enteropathy, intestinal microbiota, gut microbiota metabolite, GPR43

INTRODUCTION
Pelvic and abdominal cancers are common malignancies affecting gastrointestinal (GI),
genitourinary and gynecologic functions (Pal et al., 2019). Due to their large sizes and ease of spread
to other abdominal organs and the lymphatic system, pelvic and abdominal cancers are increasingly
being routinely treated via radiotherapy (Liauw et al., 2013; Citrin, 2017). After radiotherapy,
many patients with pelvic and abdominal cancers suffer from GI syndromes (GIS) (Peterson et al.,
2010; Hauer-Jensen et al., 2014), such as malabsorption, bacterial enteritis and diarrhea, which
adversely affect treatment and can even lead to death. These acute and chronic complications
have become major challenges for radiation oncologists and medical physicists. Therefore, the
identification of potential risk factors that may negatively influence the prognosis of cancer patients
after radiotherapy and development of novel therapeutic approaches are urgently needed.
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Emulsifiers are a class of detergent-like molecules that
are commonly added to processed foods, pharmaceutical
preparations and cosmetics. Commonly used dietary emulsifiers
include Tween, Span, sodium stearyl lactate (SSL) and propylene
glycol esters of fatty acids. For example, Tween 80 (or
polysorbate-80, P80) is a widely used food additive that
lends a smooth and stable consistency to cake, chocolate,
ice cream and other packaged snacks. In addition, P80 is
also used as a dispersal agent, solubilizer and stabilizer
for insoluble medicinal preparations (e.g., etoposide and
docetaxel injections) for cancer therapy (Iusuf et al., 2015;
Al-Ali et al., 2018). Because of its potential toxicity and
carcinogenicity, P80 has been used in limited doses (up to
1.0%) (Food Safety Commission [of Japan], 2007; Roberts
et al., 2013). However, the growing consumption of P80
over the past half-century is associated with the increasing
incidence of various chronic inflammatory and metabolic
diseases (Chassaing et al., 2015), particularly in conjunction
with alterations in the compositions and translocation of the
intestinal microbiota (Roberts et al., 2010). Ironically, cancer
patients would be given foods and medicines containing
P80 during radiotherapy. Therefore, whether consumption of
P80 adversely impairs the efficacy of radiotherapy remains
poorly understood.
The GI tract is inhabited by a community of trillions
of microbes that are collectively termed the gut microbiota
(Gopalakrishnan et al., 2018). The gut microbiota provides
crucial benefits to hosts, including the facilitation of food
digestion and development of the metabolic and immune
systems (Holmes et al., 2012; Wrzosek et al., 2013). Meanwhile,
perturbance or translocation of enteric microbes may also
result in a series of pathological processes (Clemente et al.,
2012; Lichtman et al., 2016), such as chronic colitis (Gevers
et al., 2014), Clostridium difficile-associated disease (Ghose, 2013;
Peng et al., 2018) and Crohn’s disease (Mottawea et al., 2016).
Disorders of the gut microbiota are also comorbid with a
series of psychiatric illnesses and systemic metabolic diseases,
such as anxiety (Heijtz et al., 2011), human immunodeficiency
virus (HIV) infection (Sun et al., 2016) and non-alcoholic fatty
liver disease (Chu et al., 2019). Indeed, substantial evidence
suggests a positive association between radiotherapy and the
development of colitis (Kirsch et al., 2010; Andreyev et al.,
2013), as well as significant alterations of the composition
of the gut microbiota after radiotherapy (Cui et al., 2016,
2017a).
In this study, we aimed to determine whether P80
consumption leads to detrimental alteration of the gut microbiota
and exacerbates radiation-induced intestinal injury (RIII). Our
observations demonstrated that P80 consumption altered the
composition of the gut microbiota and worsened radiationinduced GI toxicity. Importantly, administration of butyrate
by the oral route mitigated the harmful effects of P80 in
irradiated animals. Taken together, our findings identified that
P80 is a risk factor for cancer patients during radiotherapy and
indicated that butyrate might be employed as a therapeutic
option for protection against radiation-associated GI toxicity in
preclinical settings.
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MATERIALS AND METHODS
Animals
This experiment tested groups (12 mice per group) of 6–
8 weeks old male C57BL/6J mice, housed using Individual
Ventilated Cage as six mice per cage to provide a study
power of 80%. Experimental mice were treated with 200 ul
P80 (1.0% in sterile water) administered via oral route for
7 days, sterile water was used as control. No specialist equipment
was used. Cyclical bias were controlled as follows. Mice were
randomly allocated to treatment groups, no more than six mice
per cage to ensure the active area of each mouse was not
less than 0.01 m2 . Mice were maintained on clean sawdust
substrates and fed an autoclaved (60 min wet cycle) pellet
food (Cat#1022, HFK Bioscience, Beijing, China, ≤5%CHO,
≥18%PRO, ≥4%FAT/kg) and autoclaved filtered water (pH
around 5) ad libitum. To prevent dirty bedding, the bedding
material were changed every 2 days and mice in the same
cohort were blended and re-separated every 2 days throughout
the whole experiments to avoid the effects of coprophagy on
gut microbiome. Food/water were replaced every 4 days. A cohousing protocol was used before the start of all experiments.
Fresh murine feces were collected routinely in the morning the
day after cage replacement and stored for about 30 days at
−80◦ C until analysis.

Polysorbate-80 (P80) Administration
P80 was purchased from Sigma (Spain, Cat#59924). In this study,
P80 consumption was performed by oral gavage of 200 µl for
7 days (the concentration of P80, 1.0% in sterile water) to mice
before exposed to abdominal irradiation and last until the end
of the experiment. The same water was used as vehicle for the
water-treated group (control).

Radiation-Induced Intestinal Injury
Model
A Gammacell 40 Exactor (Atomic Energy of Canada Lim,
Canada) was used for all experiments. Male (approximately 20 g
in body weight) mice were treated with a single dose of 12 Gy
or 15 Gy γ-ray at a rate of 1.0 Gy/min (test by dose rate meter
carried by the Exactor) total abdominal irradiation (TAI) using
a specific steel chamber, and radiation dose was monitored by
a dose rate meter. After irradiation, the mice were returned
to the animal facility for daily observation and treatment as
described above. Mice in all groups were monitored for survival
status throughout the 30-day course of the experiment, and
then sacrificed to collect tissue samples for gross structural and
functional examinations.
R

Hematoxylin and Eosin (HE) Staining
Following euthanasia, the small intestines and colons of
mice were fixed in 4% buffered formalin overnight at room
temperature and then embedded in paraffin. Tissues were
sectioned at 5 µm thickness and dipped in hematoxylin and eosin
(Solarbio, China) using standard protocols.

2
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HPLC Chromatographic column: C18 AQ (4.6∗ 250 mm), sulfuric
acid (0.01 M) was used as the mobile phase, and the level of SCFAs
were determined by external standard calibration method.

Periodic Acid-Schiff (PAS) Staining
Small intestine tissues were fixed in Carnoy (60% dry ethanol,
30% chloroform, 10% glacial acetic acid) (Jiangtian Chemical
Technology, China) solution overnight, and 5 µm paraffin
sections were deparaffinized and oxidized in 1% periodic acid
(Solarbio, China) for 10 min, after rinsing, tissues were incubated
in Schiff ’s reagent (Solarbio, China) for 10 min, washed in warm
water, and counterstained with hematoxylin (Solarbio, China) for
30 s, washed and dehydrated before mounting.

Fecal Microbiota Transplantation (FMT)
For FMT experiments, fresh transplant materials were prepared
on the same day of transplantation within 4 h before gastric
perfusion to prevent changes in bacterial composition (Cui et al.,
2017b). Particularly, 200 mg of stools from the P80-treated mice
was re-suspended in 2 ml sterile saline, vortexed for 30 s and
allowed to stand for 30 min anaerobically. Eight-week-old male
C57BL/6J recipient mice were orally administered daily with the
supernatant for 10 days before 12 Gy TAI and maintained on
sterile water throughout the experiment.

Fecal Microbiota Analysis
For this study, stool samples were freshly collected from five
mice in different cages as described before (Cui et al., 2017b),
and then stored at −80◦ C until use. DNA was extracted from
the stool samples using the Power fecal DNA Isolation Kit
(MoBio, Carlsbad, CA, United States). The DNA was recovered
with 30 µl of buffer in the kit. The 16S ribosomal RNA
(rRNA) V4 gene amplification and sequencing were done using
the Illumina MiSeq technology. The library was sequenced
on an Illumina HiSeq 2500 and 250 bp paired-end reads
were generated. Sequence analyses were performed by Uparse
software (Uparse v7.0.10011 ). Sequences with ≥97% similarity
were assigned to the same OTUs. Representative sequence
for each OTU was screened for further annotation. For each
representative sequence, the Silva123 Database was used based
on RDP classifier (Version 2.22 ) algorithm to annotate taxonomic
information. Statistical difference of 16S rRNA high-throughput
sequencing was assessed by Tukey’s HSD. The primers are listed
in Supplementary Table S1.
R

Quantitative Real-Time Polymerase
Chain Reaction (qRT-PCR)
Total RNA was separated from the tissues or cells using Trizol
(Invitrogen, United States) according to the manufacturer’s
protocol. cDNA was synthesized from total RNA using
poly(A)- tailed total RNA and reverse transcription primer
with ImPro-II Reverse Transcriptase (Promega, United States),
according to the manufacturer’s protocol. The RT-PCR was
performed using DreamTaqTM Hot Start Green PCR Master
Mix (Thermo Fisher Scientific, CA, United States) according
to the manufacturer’s protocol. The qRT-PCR was performed
according to the instructions of Fast Start Universal SYBR
Green Master (Rox) (Roche Diagnostics GmbH, Germany).
GAPDH was used as the housekeeping gene. The expression of
gene was indicated with 2−11Ct and normalized to GAPDH.
Specifically, the calculated 2−11Ct in control group was set to
1, the expression of gene in experimental group was valued as
2−11Ct(experimental group) /2−11Ct(control group) . The primers used
in this study were listed in Supplementary Table S2.

Butyrate Administration
For butyrate treated group mice, sodium butyrate (Tokyo
Chemical Industry, Japan) was gavaged every day for 10
consecutive days after 12 Gy TAI. Fresh feces were collected
before and after 7 days of P80 treatment, as well as 7 days after
butyrate remedy, respectively, for downstream analysis.

Residual P80 Measurements
Quantification of residual P80 was performed by HPLC in
supernatants of fecal samples. The chromatographic analysis was
carried out on a Dionex Ultimate 3000 (Dionex, United States),
and the mobile phase consisted of 20 mM ammonium acetate
and acetonitrile (9:1). Following filtration through 0.45 µm
membrane, equal volume of samples was loaded onto the HPLC.
Flow rate was 0.6 ml/min, and the column temperature was 30◦ C.

Antibiotic Cocktail (ABX) Administration
ABX consisted of ciprofloxacin (0.125 g/l), metronidazole
(0.1 g/l), vancomycin (0.05 g/l), streptomycin (100 U/l) and
penicillin (100 U/l). Mice were exposed to ABX in drinking
water after TAI. The same water was used for the water-treated
(TAI+P80) group.

Short Chain Fatty Acids (SCFAs)
Measurements

Immunohistochemistry Staining (IHC)
Following euthanasia, the colons of mice were fixed in carnoy
fixation overnight at room temperature and then embedded in
paraffin. Tissues were sectioned at 5 µm thickness, and blocked
with 5% BSA (Solarbio, China) for 1 h at room temperature
and then incubated with primary antibodies overnight at
4◦ C and incubated with fluorescein isothiocyanate (FITC)conjugated goat anti-rabbit IgG antibody (ZSGB Bio, China)
for 1 h at room temperature, then stained by DAB Staining
Kit (ZSGB Bio, China), followed by hematoxylin nuclear
counterstaining. The primary antibody of rabbit anti-MUC2
(Abcam, United States) was used.

Quantification of short chain fatty acids was performed by high
performance liquid chromatography (HPLC) (Thermo Fisher,
United States) in supernatants of fecal samples reconstituted in
PBS. In brief, 1 ml of fecal solution was acidified with 1/10 volume
of H2 SO4 (0.01 M), and passed through a condenser to isolate
volatile compounds within a sample. Following filtration through
0.45 µm membrane, equal volume of samples was loaded onto the
1
2
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mice. Chronic P80-induced gains in overall weight and decrease
in colon length were not observed in short-term P80-treated mice
(Figure 1A and Supplementary Figure S1A; body weights not
shown), while short-term consumption of P80 led to loose stools
(Figure 1A). Given the important role of Glut1 (Slc2a1), Pgk,
and multidrug resistance protein (MDR) in the maintenance of
epithelial integrity (Zaki et al., 2010; Kelly et al., 2013; Winkler
et al., 2015; Cui et al., 2017b; Xiao et al., 2018), we observed
a significant reduction in the expression of Glut1 (but not
MDR and Pgk) in the P80-challenged animals (Figure 1B and
Supplementary Figures S1B,C). In addition, the tumor necrosis
factor-α (TNF-α) and pro-inflammatory cytokine interleukin 6
(IL-6) exhibited increased expressions in the small intestines
of mice subjected to short-term P80 treatment (Figures 1C,D).
Although short-term P80 consumption induced mild colitis in
mice, it did not cause histopathologic epithelial damage in the
intestines (Supplementary Figure S1D). Next, we performed
16S rRNA sequencing analysis to detect alterations in the
intestinal microbiota after short-term P80 treatment. The results
revealed a marked decrease in the numbers of intestinal bacterial
species after short-term P80 consumption (Figure 1E and
Supplementary Figures S1E,F). Principal component analysis
(PCA) further confirmed that short-term P80 administration
significantly altered the composition of the intestinal bacteria
(Figure 1F and Supplementary Figure S1G), leading to increased
abundances of Lactobacillus but decreased abundances of the
Allobaculum genus (Figure 1G).

Quantification of Fecal LCN2 and IL-10
Frozen fecal samples were re-suspended in PBS containing
0.1% Tween 20 (Jiangtian Chemical Technology, China) to
a final concentration of 0.1 g/ml, then vortexed to produce
a homogenous fecal suspension, followed by centrifuging for
10 min at 14,000 × g and 4◦ C. LCN2 and IL-10 levels were
measured from the clear supernatant using Mouse Lipocalin
(LCN2) ELISA kit (Solarbio, China) or Mouse IL-10 ELISA kit
(Solarbio, China) according to the manufacturer’s protocol. Read
the OD 450 nm value with a microtiter plate reader (Rayto,
China). Specifically, with the OD value of absorbance as the
ordinate (Y) and the concentration of the standard LCN2 (or IL10) to be measured as the abscissa (X), the corresponding curve
is made. The content of the LCN2 (or IL-10) to be measured
in the sample can be converted from the standard curve to the
corresponding concentration according to its OD value.

Cell Culture
The human enterocyte HIEC-6 cell line was cultured in RPMI1640 medium (Gibco, CA, United States) supplemented with 10%
fetal bromide serum (FBS) (Gibco, CA, United States) at 37◦ C in
a 100% humidified atmosphere of 5% CO2 .

Cell Transfection
For cell transfection, the cells were cultured in a 6-well plate for
24 h and then were transfected with siRNA. All transfections were
performed using polyetherimide (PEI) (Sigma, Spain) according
to the manufacturer’s protocol. si-GPR43 was synthesized by
RiboBio (Guangzhou, China). The sequences of siRNA were
listed in Supplementary Table S3.

P80 Consumption Aggravates RIII
To determine the effects of P80 consumption on RIII, we
repetitively administered (oral gavage) P80 daily for 7 consecutive
days before subjecting the mice to TAI. Notably, P80 treatment
reduced the survival rate (Figure 2A, p = 0.0028) and impaired
weight recovery (Figure 2B) in irradiated mice. At 30 days
post-TAI, mice were sacrificed to assess intestinal injury. The
irradiated mice with P80 challenge presented relatively short
colons, indicating severe intestinal inflammation (Figure 2C and
Supplementary Figure S2A). Histological analysis revealed that
P80 consumption decreased the number of intact intestinal villi
and goblet cells in the irradiated mice (Figures 2D,E), suggesting
that oral gavage of P80 aggravated the radiation-impaired small
intestinal epithelial integrity. Further determination of the levels
of Glut1, MDR, and Pgk in the small intestines revealed significant
reduction in expressions of these genes in the P80-challenged
animals (Figures 2F,G and Supplementary Figure S2B). Given
IL-18 plays a role in the maintenance of epithelial integrity
(Zaki et al., 2010), we observed a significant reduction in IL-18
expression in the P80-challenged animals (Figure 2H).

Statistical Analysis
Each experiment was repeated at least three times. Significance
was assessed by comparing the mean values (6 standard
deviation; SD) using Student’s t-test between each two cohort
as follows: *p < 0.05, **p < 0.01, ***p < 0.001. Statistically
difference of 16S rRNA high throughput sequencing was
assessed by TukeyHSD and the data were analyzed controlling
for cage-clustering. Kaplan–Meier analysis was performed for
survival analysis, and significance between survival curves was
determined by a log rank test. Results with p < 0.05 were
considered statistically significant. The statistical tests were
clarified in related legends. Kernel-density-violin plots were used
to determine the sample sizes and data distribution (Basson et al.,
2020a).

RESULTS

P80 Consumption Exacerbates
Radiation-Induced GI Toxicity Through
the Gut Microbiota

P80 Consumption Shifts the Gut
Microbial Profile
In light of a recent finding that chronic P80 consumption (for
12 weeks) caused detrimental alteration of the gut microbial
profile and promoted colitis (Chassaing et al., 2015), we examined
whether inflammation and alteration of the gut microbiota were
induced by a relatively short-term P80 challenge (for 7 days) in

Frontiers in Microbiology | www.frontiersin.org

To elucidate the mechanism underlying the P80-mediated
aggravation of irradiation injury, we performed 16S rRNA
sequencing using fecal pellets from the mice to characterize
the composition of the gut microbiota. The mice were fed the
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FIGURE 1 | P80 consumption promotes intestinal inflammation and alters the gut microbiota. (A) The length of colon tissues from mice with or without consumption
of P80 by oral gavage was shown. (B–D) The expression levels of Glut1 (B), TNF-α (C) and IL-6 (D) in small intestines were examined by qRT-PCR. Significant
differences are indicated: *p < 0.05, ***p < 0.001; Student’s t-test, n = 12 per group. (E) The observed species number of intestinal bacteria in mice before and after
7 days of consumption of P80 was examined by 16S rRNA high throughput sequencing. The top and bottom boundaries of each box indicate the 75th and 25th
quartile values, respectively, and lines within each box represent the 50th quartile (median) values. Ends of whiskers mark the lowest and highest diversity values in
each instance. Statistically significant differences are indicated: *p < 0.05; TukeyHSD, n = 5. (F) The β diversity of intestinal bacteria in mice before and after 7 days
of consumption of P80 was examined by 16S rRNA high throughput sequencing. Statistically significant differences are indicated: **p < 0.01; TukeyHSD, n = 5.
(G) The relative abundances of enteric bacteria at the phylum level in mice before and after 7 days of consumption of P80 were assessed using 16S rRNA high
throughput sequencing.

further confirmed that P80-challenged mice exhibited significant
changes in the gut microbial composition following TAI
(Figure 3L). To elaborate, TAI elevated the relative frequency of
Bacteroides but reduced that of the Lachnospiraceae_NK4A136
group at the genus level (Supplementary Figure S3B),
whereas P80 administration increased the relative frequency
of Bacteroidetes but decreased that of Lactobacillus in
TAI-exposed mice (Supplementary Figure S4B). Further
analysis of the gut bacterial composition at the genus level
revealed increased abundances of Candidatus_Stoquefichus,
Parabacteroides, Bacteroides, Turicibacter, Erysipelatoclostridium
and Ruminococcus_1 in the irradiated mice (Supplementary
Figure S3C). In contrast, mice exposed to irradiation after P80
consumption harbored high relative abundances of bacterial
genera belonging to the phyla Firmicutes and Bacteroidetes, such
as Lactobacillus, Anaerotruncus, Roseburia and Rikenella, but low
relative abundances of bacterial genera belonging to the phyla
Proteobacteria and Actinobacteria, including Parasutterella and
Akkermansia (Supplementary Figure S4C).

same rodent chow and sterile water in a specific-pathogenfree (SPF) animal facility for at least 3 days to make the
microbiota of the mice accordant (Figure 3A). Interestingly,
TAI exposure alone did not change the α-diversity of the enteric
bacteria (Figure 3B and Supplementary Figure S3A), while
TAI following P80 consumption altered the α-diversity of the
gut microbiota (Figure 3C and Supplementary Figure S4A).
We also assessed the species number of enteric bacteria in
irradiated mice with or without P80 treatment and observed
no significant alterations (Figure 3D). Furthermore, PCA
analysis and unweighted_unifrac algorithm further confirmed
that, when the initial community configurations were similar
(Figures 3E,I), TAI alone did not change the composition of the
gut microbiota (Figures 3F,J), but P80 consumption significantly
shifted that in irradiated animals (Figures 3G,K). Notably,
although the species number of intestinal bacteria showed no
changes in irradiated mice with or without P80 consumption, the
PCA showed a separation of microbiota composition between
the two cohorts (Figure 3H), unweighted_unifrac algorithm

Frontiers in Microbiology | www.frontiersin.org
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FIGURE 2 | P80 consumption aggravates RIII. (A) Mice received 7 days of oral gavage with water or P80 before TAI. Kaplan–Meier survival analysis was performed.
p = 0.0028 by log-rank test, n = 12 per group. (B) The body weight was measured using two-way group ANOVA (*p < 0.05), n = 12 per group. (C) The length of
colon tissues from irradiated mice was measured at 30 days after TAI. Statistically significant differences are indicated: *p < 0.05, **p < 0.01; Student’s t-test, n = 12
per group. (D) The morphologies of the small intestines of mice were shown by HE and PAS staining. (E) The number of goblet cells per crypt was counted.
Statistically significant differences are shown relative to the “TAI” group: **p < 0.01; Student’s t-test between each two cohorts, n = 5 per group. (F–H) The
expression levels of MDR (F), Pgk (G) in small intestines and IL-18 (H) in colon tissues were examined by qRT-PCR. Significant differences are indicated: none
significance (NS), *p < 0.05, ***p < 0.001; Student’s t-test, n = 12 per group.

remains undetectable in feces after oral gavage (Supplementary
Figure S5A). Thus, we performed FMT (Figure 4A) and
antibiotic treatment to validate the role of gut microbes in
P80-exacerbated radiation toxicity. Although FMT did not
affect the body weights of the animals (Figure 4B), mice

To eliminate the effects of residual P80 in stools on
recipients, we performed HPLC to measure the residual
P80 in feces of mice that received water (control group)
or P80 for 7 consecutive days. The results showed no
significant difference between the two groups, indicating that P80

Frontiers in Microbiology | www.frontiersin.org
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FIGURE 3 | P80 alters the gut microbiota composition of irradiated mice. (A–D) The observed species number of intestinal bacteria was examined by 16S rRNA
sequencing before (or at 7 days after) 12 Gy TAI. Mice were treated with water (TAI group) or P80 (TAI+P80 group), respectively. Statistically significant differences are
indicated: none significance (NS), *p < 0.05; TukeyHSD, n = 5 per group. (E–L) The PCA (E–H) and β diversity (I–L) of intestinal bacteria in mice before (or at 7 days
after) TAI were examined by 16S rRNA sequencing. The top and bottom boundaries of each box indicate the 75th and 25th quartile values, respectively, and lines
within each box represent the 50th quartile (median) values. Ends of whiskers mark the lowest and highest diversity values in each instance. Statistically significant
differences are indicated: none significance (NS), *p < 0.05; TukeyHSD, n = 5 per group.

that received gut microbes from P80-challenged mice exhibited
susceptibility to irradiation, leading to slightly decreased
survival rates (Figure 4C, p = 0.2589), relatively short
colons (Figure 4D and Supplementary Figure S5B) and
reduced levels of intestinal integrity markers (Figure 4E
and Supplementary Figures S5C,D). Consistent with the
results of FMT, when we used an antibiotic cocktail (ABX,
named “TAI+P80+ABX”) to eliminate the intestinal microbiota
of P80-treated mice following TAI, the mice that were
administered ABX exhibited increased weight loss (Figure 4F),
decreased colon lengths (Figure 4G and Supplementary
Figure S5E) and reduced intestinal integrity (Figure 4H and
Supplementary Figures S5F,G), suggesting that alteration of
the gut microbiota might be a response to P80 consumptionexacerbated GI toxicity after radiation exposure. Notably,
ABX administration induced relatively low grade inflammation
(TNF-α, p = 0.014; IL-6, p = 0.117) (Figure 4I and Supplementary

Frontiers in Microbiology | www.frontiersin.org

Figure S5H); however, it might be inadequate to alleviate P80aggravated RIII.

Butyrate Replenishment Attenuates
P80-Aggravated GI Toxicity Following
Irradiation
Given the protective effects of SCFAs against intestinal epithelial
injury (Fukuda et al., 2011; Smith et al., 2013; Kelly et al.,
2015), we measured the concentrations of SCFAs in fecal
pellets of mice in different cohorts using HPLC. The acetate
levels remained unchanged in irradiated and P80-treated
animals (Supplementary Figure S6A). However, the butyrate
levels decreased in the feces of irradiated animals and further
decreased in the animals subjected to P80 exposure combined
with irradiation (Figure 5A). In contrast, the propionate
levels increased in the feces of irradiated mice and further
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FIGURE 4 | Alteration in the gut microbiota aggravates RIII. (A–E) Mice were separated into two groups randomly. Before 15 Gy γ ray exposure, one cohort was
treated with saline as control (named saline-treated FMT), the other was treated with intestinal microbes of P80-challenged mice in saline (named P80-treated FMT).
(A) Scheme for FMT. (B) Mice received 10 days of oral gavage with saline or FMT, the body weight was measured after TAI using two-way group ANOVA (*p < 0.05).
n = 8 per group. (C) Kaplan–Meier survival analysis of mice was performed after TAI. p = 0.2589 by log-rank test between con and FMT group, n = 8 per group.
(D) The length of colon tissues was measured at 15 days after TAI. Statistically significant differences are indicated: *p < 0.05; Student’s t-test, n = 8 per group.
(E) The expression level of Glut1 was examined in small intestine tissues by qRT-PCR. Significant differences are indicated: **p < 0.01; Student’s t-test, n = 8 per
group. (F–I) Mice were separated into two groups randomly. Before 12 Gy γ ray exposure, mice were treated with P80 by oral gavage for 7 days, then one cohort
was treated with sterile water (named TAI+P80), the other was treated with antibiotic cocktail (named TAI+P80+ABX). (F) Mice received water or ABX treatment, the
body weight was measured using two-way group ANOVA (*p < 0.05), n = 12 per group. (G) The length of colon tissues was shown at 15 days after TAI. (H,I) The
expression levels of Glut1 (H) and TNF-α (I) in small intestine tissues were examined by qRT-PCR. Significant differences are indicated: *p < 0.05, ***p < 0.001;
Student’s t-test, n = 12 per group.

elevated by irradiation following P80 exposure (Supplementary
Figure S6B). Thus, we evaluated the therapeutic potency of
butyrate toward P80-exacerbated GI injury following TAI. Using
a mouse model of TAI, we observed that butyrate improved
survival rate reduction (slightly, from 78.6% to 85.7%) and
body weight loss of P80-challenged mice following radiation
in a dose-dependent manner (Figures 5B,C), suggesting that
butyrate treatment might alleviate P80-aggravated irradiation
injury. We chose the effective concentration of butyrate
(high, 7.5 mg/ml) to further study its role in protecting
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radiation enteritis. As shown in Figure 5 and Supplementary
Figure S6, oral gavage of butyrate restored the length and
structure of the colon (Figures 5D,E and Supplementary
Figure S6C), as well as increased the number of intact intestinal
villi and goblet cells in the small intestines (Figure 5F).
The genes involved in maintenance of epithelial integrity
were upregulated in the butyrate-treated cohort (Figure 5G
and Supplementary Figures S6D–F). Moreover, butyrate
treatment eliminated the alterations in LCN2 and IL-10
levels in feces driven by P80 consumption (Figures 5H,I),
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FIGURE 5 | Butyrate prevents the P80-aggravated irradiation injury. (A) The concentration of butyrate in different fecal samples was analyzed by HPLC. Significant
differences are indicated: *p < 0.05; Student’s t-test, n = 12 per group. (B) Kaplan–Meier survival analysis of mice after irradiation was performed. p = 0.0102
between TAI and TAI+P80 group by log-rank test; n = 14 per group. TAI group was treated with water before and after TAI as control, TAI+P80 group was treated
with P80 for 7 days before irradiation and water after irradiation, TAI+P80+butyrate group was treated with P80 before irradiation and different concentrations of
butyrate after irradiation (low, 3.75 mg/ml; high, 7.5 mg/ml). (C) The body weight of mice was measured after 12 Gy TAI using two-way group ANOVA (# p < 0.05
compared between TAI+P80 and TAI+P80+butyrate (l), *p < 0.05 compared between TAI+P80 and TAI+P80+butyrate (h); n = 14 per group. (D) The length of colon
tissues was measured at 30 days after TAI. Significant differences are indicated: *p < 0.05, **p < 0.01; Student’s t-test. (E) The morphology of the colon (upper
panel) was shown by HE staining. Immunohistochemical showed expression of MUC2 in the colons of mice (lower panel). (F) The morphology of the small intestines
was shown by HE and PAS staining. The arrows pointed to the goblet cells. (G) The expression level of Glut1 in small intestine tissues was examined by qRT-PCR.
Significant differences are indicated: ***p < 0.001; Student’s t-test, n = 12 per group. (H) Fecal level of the inflammatory marker LCN2 was examined by ELISA.
Statistically significant differences are indicated: *p < 0.05, ***p < 0.001; Student’s t-test, n = 12 per group. (I) The concentration of IL-10 in feces was examined by
ELISA. Significant differences are indicated: *p < 0.05, ***p < 0.001; Student’s t-test, n = 12 per group. (J) The expression level of GPR43 in the colons was
examined by qRT-PCR. Significant differences are indicated: **p < 0.01, ***p < 0.001; Student’s t-test, n = 12 per group.

indicating that butyrate might be able to combat low-level
intestinal inflammation.
Given that butyrate is an important energy substrate (Buzzetti
et al., 2016), we observed that butyrate treatment upregulated the
expression of Mgam, Glut2 and Sglt1 expression (Supplementary
Figures S6G–I), which are essential genes for digestion and
energy absorption (Sainz et al., 2015; Barron et al., 2016; Buzzetti
et al., 2016). Previous studies have shown that the mechanism
underlying the SCFAs effect partially involves G-protein-coupled
receptors (GPCRs) (Macia et al., 2015). Therefore, we measured
the expression of GPR41 and GPR43, both of which are major
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GPCRs activated by SCFAs. The results showed that the levels of
these two GPCRs were increased in the butyrate-treated cohort
(Figure 5J and Supplementary Figure S6J).
To determine whether butyrate could alleviate common
radiation-induced injury, we performed water (as a control)
or butyrate administration by the oral route. As expected,
butyrate treatment resulted in significant gains in body weight
and amelioration of tissue damage (Figures 6A,B). Butyrate
also reduced multiple parameters of inflammation in mice,
including colon length (Figures 6C,D) and expression levels of
integrity markers in intestines (Figures 6E–H). To determine
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FIGURE 6 | Butyrate educates P80-aggravated GI injury involving GPCRs. (A) The body weight of mice was measured after 12 Gy TAI using two-way group ANOVA
(*p < 0.05), n = 12 per group. (B) The morphologies of the intestine (upper panel) and colon (lower panel) of mice were shown by HE staining. (C,D) The length of
colon tissues of mice was measured at 30 days after 12 Gy TAI. Significant differences are indicated: *p < 0.05; Student’s t-test, n = 12 per group. (E–H) The
expression levels of Glut1 (E), MDR (F) and Pgk (G) in small intestines and IL-18 (H) in colon tissues of mice were examined by qRT-PCR. Significant differences are
indicated: **p < 0.01, ***p < 0.001; Student’s t-test, n = 12 per group. (I) The expression level of GPR43 in the HIEC-6 cells with butyrate and with or without
knockdown of the GPR43 expression was examined by quantitative PCR. (J,K) The expression levels of GPR41 (J) and GPR43 (K) in HIEC-6 cells with or without
siGPR43 transfection were examined by qRT-PCR. Significant differences are indicated: *p < 0.05, **p < 0.01; Student’s t-test.

the mechanism underlying the modulation of radiation injury
by butyrate, we supplied HIEC-6 cells with butyrate and with
or without knockdown of the GPR43 expression by siRNA
(Figure 6I). Similar to the results obtained in mouse models,
butyrate treatment significantly upregulated the expression
of GPR41 and GPR43, while GPR43 siRNA transfection
downregulated GPR41 and GPR43 (Figures 6J,K).

butyrate replenishment (Figure 7A). For comparison, the gut
bacterial taxonomic proportions of mice from the control group
(non-irradiated and non-P80-treated) exhibited no statistically
significant difference before and after 14 days of feeding
(Supplementary Figures S7A–D). However, supplementation
with butyrate significantly attenuated the P80-induced shift
in the gut microbial profile (Figures 7B,C). PCA further
confirmed that supplementation with butyrate attenuated the
P80-induced intestinal bacterial composition (Figures 7D,E).
Specifically, the P80-treated mice harbored increased abundances
of Proteobacteria and decreased abundances of Firmicutes after
TAI. However, oral gavage of butyrate stabilized the abundance
of Proteobacteria and increased the abundance of Firmicutes
(Figure 7F). Moreover, butyrate administration elevated
the relative abundances of Parabacteroides, [Eubacterium],

Oral Gavage of Butyrate Prevents
P80-Mediated Alteration of the Gut
Microbiota
To elucidate the mechanism underlying butyrate-mediated
protection, we performed 16S rRNA sequencing to assess
the intestinal bacterial composition of mice with or without
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FIGURE 7 | Butyrate alters the fecal microbiota. (A) Experimental design. “Water” group is short for “TAI+P80+water” group, “butyrate” group is short for
“TAI+P80+butyrate” group. (B,C) The observed species number (B) and Chao 1 index (C) of intestinal bacteria of mice were examined by 16S rRNA sequencing.
Statistically significant differences are indicated: non significance (NS), *p < 0.05; TukeyHSD, n = 5 per group. (D,E) The PCA (D) and β diversity (E) of intestinal
bacteria in irradiated mice were examined by 16S rRNA sequencing. Statistically significant differences are indicated: non significance (NS), *p < 0.05; TukeyHSD,
n = 5 per group. (F) The relative abundance of intestinal bacteria at the phylum level of irradiated mice was assessed using 16S rRNA sequencing. (G) The relative
abundance of enteric bacteria at the genus level of irradiated mice was assessed using 16S rRNA sequencing.

Rikenellaceae, Turicibacter and Bifidobacterium at the genus
level and concurrently reduced the abundances of Odoribacter,
Anaerotruncus and the Lachnospiraceae_NK4A136 group
(Figure 7G and Supplementary Figure S7E).

effects on human health. For instance, artificial sweeteners
have recently been reported to cause glucose intolerance in
humans (Suez et al., 2014). Similarly, there is an on-going
debate regarding a possible association between the addition
of thiomersal in vaccines and the development of autism
(Siva, 2012). Dietary emulsifiers, such as carboxymethylcellulose
(CMC) and P80, have been reported to impair the mucus layer
and alter the composition of the intestinal microbiota, resulting
in colitis and metabolic syndrome (Chassaing et al., 2015). The
intestinal tract is home to a complex and diverse microbial
flora, which interacts with the gut epithelium to maintain an
effective mucosal barrier that is important for the maintenance
of homeostasis (Brown et al., 2015; Zanvit et al., 2015). Recent
investigations have demonstrated that non-nutritive sweeteners
and dietary emulsifiers consumption shape the gut microbiome,
resulting in intestinal disturbance and inflammation, spurring
the development of the metabolic syndrome and detrimentally

DISCUSSION
During the past half-century, we have witnessed a steep rise in
the consumption of food and medicine additives. These agents
include spices, sweeteners, preservatives and emulsifiers, which
are added to preserve the flavor or enhance the taste, appearance,
or other qualities of foods and medicines. The primary basis
for approving the usage of the additives is the notion that
they fail to favor toxicity at concentrations reasonably greater
than the approved concentrations. Of late, mounting evidence
corroborates that many of these additives may have harmful
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inhibitors and GPCRs ligands governing host metabolism and
immunity (Chung et al., 2016; Koh et al., 2016). In comparison
with radiation-free mice here, TAI exposure downregulated
butyrate levels, a member of SCFAs, which was further decreased
in fecal pellets of mice subjected to P80 challenge. Since
Allobaculum is thought to be a beneficial bacterium, which
plays anti-inflammatory role, protects gut barrier function and
regulates host metabolism and immunity by producing SCFAs in
the intestine (Cox et al., 2014; Ma et al., 2020). Thus, P80-treated
mice may harbor lower relative abundance of Allobaculum in
the intestinal microbiota. Butyrate supplementation hinders the
development of hepatitis and colitis (Zhang et al., 2016; Sheng
et al., 2017), implying that butyrate might be harnessed to protect
against radiation toxicity. To test this hypothesis, we performed
a butyrate “rescue” experiment in which butyrate was artificially
supplied via the oral route. We treated P80-challenged mice
with butyrate at concentration of 3.75 mg/ml and 7.5 mg/ml
and results showed that butyrate performed therapeutic effects
in a dose-dependent manner. Then, we used the optimal dose
of butyrate (7.5 mg/ml) throughout the study. As expected,
butyrate replenishment significantly restored the P80-shifted
gut microbial composition, and mitigated P80-aggravated GI
toxicity in irradiated animals. Generally, radiation-induced GI
tract injury represents as shortening of colon, losing of intestinal
villi and decreasing of goblet cells. In addition, emulsifiers intake
propelled epithelial damage of small intestine and shortened
colons. All the evidence indicates that small intestine might be
vulnerable to external stimulus and shows structural damage,
and contraction in length of colon might be a marker for
GI tract toxicity following radiation. Concerning the possible
mechanism by which SCFAs modulate host responses, previous
study suggests that human genome possesses approximately 800
GPCRs, and lately a cluster of four GPCR genes is identified
in close proximity to the CD22 gene on chromosome 19q13.1.
Luminal SCFAs are sensed by GPCRs, releasing bioactive factors
to impact satiety, inflammation and intestinal transit (Koh et al.,
2016). In line with the previous implications, the underlying
mechanism by which butyrate performs radiation protective
effects partly dependents on binding and activating GPCR. In
addition, 16S rRNA sequencing indicated butyrate replenishment
reconstructed the enteric bacteria composition of irradiated mice,
suggesting that the gut microbe pattern is the essential element
to sustain butyrate-mediated radiation toxicity. Taken together,
our findings suggest that butyrate, a metabolite of the gut
microbiota, can be employed as a therapeutic agent to attenuate
P80-aggravated GI injury following radiotherapy.

influence anxiety-related and social behaviors (Suez et al., 2014;
Chassaing et al., 2015; Holder et al., 2019). For more than
10 years, microbial configuration has been associated with
radiosensibility in both humans and mouse models (Sokol and
Adolph, 2018). Notably, the data presented in our previous
studies have shown that regular work-rest cycle and FMT fought
against radiation toxicity via modulating gut microbiome (Cui
et al., 2016, 2017b). Specifically, it has been reported in our
previously studies that TAI had no effect on the abundance of the
intestinal bacterial of mice after 3 days (Cui et al., 2017a), 5 days
(Xiao et al., 2018) and 6 or 12 days (Li et al., 2020) of TAI. In
addition, recently study reported that after 1 month of TAI, there
was no significant change in the abundance of gut microbiota
(Lu et al., 2019). All the studies prove that TAI unchanges the
α-diversity of gut microbiota in hosts. However, in light of PCA
analysis in this study and principal coordinates analysis (PCoA)
analysis in our another study (Li et al., 2020), TAI exposure
spurred the separation of gut microbiota, suggesting that TAI
might alter the composition of intestinal microbe configurations.
Moreover, germ-free mice, which lack colonizing microbes, are
resistant to radiation-induced lesions, indicating that the gut
microbiota indeed relates to radiation-induced intestinal damage
(Crawford and Gordon, 2005). Accordingly, we conjectured
that P80 might be a potential risk factor for cancer patients
receiving radiotherapy. To test this hypothesis, we performed
TAI exposure mouse models with P80 consumption. As expected,
the experimental mice exhibited more deteriorate symptom.
It suggests that P80 might be an adverse agent for cancer
patients receiving radiotherapy. Therefore, the medication and
diet of cancer patients with radiation therapy need monitoring.
In particular, the intake of P80 should be strictly limited so
as not to impair the prognosis. Cage-clustering effect is a key
interference factor for studies on gut microbes using mouse
models (Rodriguez-Palacios et al., 2018; Basson et al., 2020b).
Here, it should be noted that although we controlled the cyclical
bias by maintaining relative clean bedding material and providing
sterile diet and water, the cage-clustering effect always exists in
this system as the limitation of studies using mouse data, unless
mice are housed individually, or statistical methods are used to
control for cage effects.
The human GI tract harbors trillions of microbes, constituting
a bioreactor fueled by dietary macronutrients to produce
bioactive molecules. Many microbial products might emerge
as messengers between gut microbes and hosts, and play
pivotal roles in governing the physiological processes of hosts,
ranging from metabolism to brain function. For example, a
great majority of 5-hydroxytryptamine is synthesized in the
GI tract, modulating various biological processes, including the
function of the GI, cardiac and respiratory systems as well as
platelet aggregation (Kishi et al., 2013). Likewise, other microbial
products, such as betaine, trimethylamine N-oxide (TMAO) and
choline, are also involved in the development of cardiovascular
diseases (Wang et al., 2011). Bile acids, which are major intestinal
metabolites, may have beneficial effects on obesity and hepatic
insulin sensitivity (Tagawa et al., 2015; Kusumoto et al., 2017).
SCFAs are a group of major fermentation products from dietary
fibers by microorganisms in the gut, serve as histone deacetylases
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